Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | PER2 | O15055 | 1/20 | 0.35 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.35 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13725381 | 0.94 | TSPO (0.34) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL13725885 | 0.93 | KDM4E (0.42) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL9912902 | 0.93 | HTT (0.42) | NPSR1L3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL21974343 | 0.91 | L3MBTL1 (0.39) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL21974347 | 0.91 | L3MBTL1 (0.39) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL13725132 | 0.90 | L3MBTL1 (0.33) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL13725692 | 0.90 | L3MBTL1 (0.33) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL13291211 | 0.90 | TSPO (0.35) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL13724932 | 0.90 | KDM4E (0.44) | NPSR1L3MBTL1HTTAKR1C4AKR1C3 | |
| SCHEMBL12242932 | 0.90 | L3MBTL1 (0.47) | NPSR1L3MBTL1HTTKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394511-B2 | Compound for forming organic film, and organic light emitting device and flat panel display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8394511-B2 | Compound for forming organic film, and organic light emitting device and flat panel display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-08-13 | — | — | US | disclosed |
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SLCO4C1, PORCN, SLC7A5 | NPSR1 4841/4885L3MBTL1 1723/4885HTT 1888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.